The Antiemetic Profile of Zacopride
The antiemetic activity of zacopride against a variety of emetogenic agents has been determined in dogs. Zacopride was highly effective in inhibiting emesis due to a wide range of cancer chemotherapeutic agents, particularly cisplatin. It was well absorbed orally since the dose of zacopride required to inhibit cisplatin-induced emesis in dogs by 90% was 28 μg kg−1 both by i.v. and p.o. routes. Further, zacopride (1 mg kg−1 p.o.), administered after the onset of cisplatin-induced emesis, reduced the number of subsequent emetic episodes by 91%. Zacopride at 0·1, 1, or 3·16 mg kg−1 p.o. or i.v., reduced the number of emetic episodes due to dacarbazine, mechlorethamine, adriamycin, actinomycin D, or peptide YY by 100, 100, 86, 96 and 79%, respectively. However, zacopride was not effective in inhibiting emesis due to either apomorphine, copper sulphate, protoveratrine A, histamine, or pilocarpine. No adverse effects attributed to zacopride were observed. Zacopride is thus a unique and potent antiemetic agent as it selectively inhibits the emetic response to cancer chemotherapy agents and peptide YY.
Топ-30
Журналы
|
2
4
6
8
10
12
14
|
|
|
European Journal of Pharmacology
14 публикаций, 34.15%
|
|
|
Journal of Cardiovascular Pharmacology
2 публикации, 4.88%
|
|
|
Journal of Pharmacological Sciences
2 публикации, 4.88%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 2.44%
|
|
|
Cancer Chemotherapy and Pharmacology
1 публикация, 2.44%
|
|
|
Russian Chemical Reviews
1 публикация, 2.44%
|
|
|
PLoS ONE
1 публикация, 2.44%
|
|
|
Life Sciences
1 публикация, 2.44%
|
|
|
European Journal of Pharmacology Molecular Pharmacology
1 публикация, 2.44%
|
|
|
Cancer Treatment Reviews
1 публикация, 2.44%
|
|
|
Neuroscience Letters
1 публикация, 2.44%
|
|
|
The Japanese Journal of Pharmacology
1 публикация, 2.44%
|
|
|
Neuropharmacology
1 публикация, 2.44%
|
|
|
Autonomic Neuroscience: Basic and Clinical
1 публикация, 2.44%
|
|
|
British Journal of Pharmacology
1 публикация, 2.44%
|
|
|
Drug Development Research
1 публикация, 2.44%
|
|
|
Journal of Neurochemistry
1 публикация, 2.44%
|
|
|
Journal of Physiology
1 публикация, 2.44%
|
|
|
Medicinal Research Reviews
1 публикация, 2.44%
|
|
|
Journal of Pharmacy and Pharmacology
1 публикация, 2.44%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
1 публикация, 2.44%
|
|
|
Journal of the American Society of Nephrology : JASN
1 публикация, 2.44%
|
|
|
Trends in Neurosciences
1 публикация, 2.44%
|
|
|
Expert Review of Clinical Pharmacology
1 публикация, 2.44%
|
|
|
2
4
6
8
10
12
14
|
Издатели
|
5
10
15
20
25
30
|
|
|
Elsevier
27 публикаций, 65.85%
|
|
|
Wiley
6 публикаций, 14.63%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 публикации, 7.32%
|
|
|
Springer Nature
2 публикации, 4.88%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.44%
|
|
|
Public Library of Science (PLoS)
1 публикация, 2.44%
|
|
|
Taylor & Francis
1 публикация, 2.44%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.